ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      87.015
      0.12%
      Bitcoin
      57,301.50
      -4.76%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axovant Gene Therapies Ltd (AXGT)

      7. Axovant Gene Therapies Ltd (AXGT) News

      AXGT

      Axovant Gene Therapies (AXGT)

      Axovant Gene Therapies Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXGT
      DateTimeSourceHeadlineSymbolCompany
      03/19/20194:59PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/19/20194:58PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/19/20194:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/19/20194:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/19/20194:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/19/20194:18PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/15/20196:20AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/15/20196:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/14/20197:00AMGlobeNewswire Inc.Axovant Sciences Announces Pricing of $40 Million Public Offering of Common SharesNASDAQ:AXGTAxovant Gene Therapies Ltd
      03/13/20196:54PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/13/20194:21PMGlobeNewswire Inc.Axovant Sciences Announces Public Offering of Common SharesNASDAQ:AXGTAxovant Gene Therapies Ltd
      03/06/20195:31PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/04/20194:37PMEdgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)NASDAQ:AXGTAxovant Gene Therapies Ltd
      03/04/20197:00AMGlobeNewswire Inc.Axovant to Present at Cowen and Company 39th Annual Health Care ConferenceNASDAQ:AXGTAxovant Gene Therapies Ltd
      02/21/20198:00AMGlobeNewswire Inc.Axovant to Host First R&D Day March 29, 2019NASDAQ:AXGTAxovant Gene Therapies Ltd
      02/21/20196:02AMEdgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)NASDAQ:AXGTAxovant Gene Therapies Ltd
      02/20/20194:40PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXGTAxovant Gene Therapies Ltd
      02/19/20197:00AMGlobeNewswire Inc.Axovant to Present at 8th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:AXGTAxovant Gene Therapies Ltd
       Showing the most relevant articles for your search:NASDAQ:AXGT

      Your Recent History

      BIT
      UB0P2M
      UniCredit Bank
      Delayed Upgrade Clock